Acute coronary syndrome (ACS) represents a significant global health burden. Rapid advancements in its management have improved patient outcomes substantially.
Newer antiplatelet agents such as Ticagrelor and Prasugrel have demonstrated superior efficacy compared to traditional therapies. The advent of novel anticoagulants has also enhanced ACS management.
Advancements in percutaneous coronary intervention (PCI) techniques, including drug-eluting stents and bioresorbable vascular scaffolds, have revolutionized ACS treatment. Moreover, early invasive strategies have shown significant mortality benefits.
Cardiac rehabilitation programs, focusing on exercise training, nutritional counseling, and stress management, have gained prominence in post-ACS care, contributing to improved patient quality of life.
Continued innovation in ACS management, from pharmacological interventions to procedural techniques and post-acute care, holds significant promise for the future. A comprehensive understanding of these advancements is essential for healthcare professionals to optimize patient outcomes.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation